The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...